Atlas Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 160
Employees
  • Latest Deal Type
  • Corporate
  • Latest Deal Amount
  • $11.6M
Latest Deal Amount
  • Investors
  • 4

Atlas General Information

Description

Developer of DNA and microbiome testing kits for use at home designed to help people adopt a positive lifestyle change and get a healthier future. The company's testing kits help the users to take control of their health through actionable and personalized recommendations, enabling patients to discover the ratio of neanderthal genes, the impact of genetics on their traits such as odor sensitivity and iris structure and their metabolism of vitamins and micronutrients and learn food recommendations.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Medical Supplies
Laboratory Services (Healthcare)
Primary Office
  • Tintagel House
  • 92 Albert Embankment, Lambeth
  • London SE1 7TY
  • England, United Kingdom

Atlas Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Atlas Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Corporate 19-Nov-2020 $11.6M 000.00 000.00 Completed Generating Revenue
4. Accelerator/Incubator 27-Mar-2018 00.000 Completed Generating Revenue
3. Early Stage VC 09-Jan-2018 00.000 00.000 000.00 Completed Generating Revenue
2. Early Stage VC 11-Jul-2017 $2.02M $2.09M 000.00 Completed Generating Revenue
1. Early Stage VC 01-Jan-2016 $72.3K $72.3K Completed Generating Revenue
To view Atlas’s complete valuation and funding history, request access »

Atlas Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 00000.00 00000.00 00 00000.00 00.000
Ordinary 000 00.000000 00000.00 00000.00 00 00000.00 0.000
Ordinary 000 00.000000 00000.00 00000.00 00 00000.00 0.000
Ordinary 527 $0.013089 $1931.77 $1931.77 1x $1931.77 2.2%
Ordinary 526 $0.013089 $1981.54 $1981.54 1x $1981.54 2.19%
To view Atlas’s complete cap table history, request access »

Atlas Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of DNA and microbiome testing kits for use at home designed to help people adopt a positive lifestyle change a
Biotechnology
London, United Kingdom
160 As of 2021
000.00
00.00 0000-00-00
000000000000 000.00

00000

ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
0000000000000
Bellevue, WA
000 As of 0000
00000
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Atlas Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000 Venture Capital-Backed Bellevue, WA 000 00000 0000000000 0 00000
You’re viewing 1 of 1 competitors. Get the full list »

Atlas Patents

Atlas Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3859739-A1 Phenotype inference based on incomplete genetic data Pending 03-Feb-2020 000000000 0
US-20190259501-A1 Method for evaluation of disease risk in the user on the basis of genetic data and data on the composition of gut microbiota Abandoned 15-Feb-2018 000000000
EP-3693972-A1 System and method for interpreting data and providing recommendations to a user based on his/her genetic data and on data related to the composition of his/her intestinal microbiota Pending 03-Oct-2017 000000000
EP-3693972-A4 System and method for interpreting data and providing recommendations to a user based on his/her genetic data and on data related to the composition of his/her intestinal microbiota Pending 03-Oct-2017 G16H50/30

Atlas Executive Team (5)

Name Title Board Seat Contact Info
Sergey Musienko Co-Founder, Chief Executive Officer & Board Member
Michael Sassarini Chief Financial Officer
Artem Kosarev Chief Product Officer and Director, Product
Alexander Krylov Technical Director
You’re viewing 4 of 5 executive team members. Get the full list »

Atlas Board Members (3)

Name Representing Role Since
Sergey Musienko Atlas Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 1 of 3 board members. Get the full list »

Atlas Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atlas Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Streitum Corporation Minority 000 0000 000000 0
EIT Digital Accelerator/Incubator 000 0000 000000 0
Primer Capital Venture Capital Minority 000 0000 000000 0
SETsquared Partnership Accelerator/Incubator Minority 000 0000 000000 0
To view Atlas’s complete investors history, request access »

Atlas Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 00000000 01-Oct-2015 000000000000000000 Biotechnology
To view Atlas’s complete acquisitions history, request access »

Atlas Subsidiaries (1)

Company Name Industry Location Founded
000 00000000 Biotechnology Moscow, Russia
To view Atlas’s complete subsidiaries history, request access »